Skip to content

Clinical trials

Anemia, Sickle Cell trials in Saudi Arabia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anemia, Sickle Cell Country / region: Saudi Arabia Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20141
20152
20161
20191
20201
20214
20225
20231
20241
20254

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated7
Recruiting6
Completed5
Active, not recruiting2
Not yet recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer5
ApoPharma2
Imam Abdulrahman Bin Faisal University2
Novo Nordisk A/S2
Afnan Bkri1
Agios Pharmaceuticals, Inc.1
Beni-Suef University1
Eli Lilly and Company1
Forma Therapeutics, Inc.1
Majmaah University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anemia, Sickle Cell22
Vaso-Occlusive Crises6
Hematologic Diseases5
Sickle Cell Trait3
Genetic Diseases, Inborn2
Hemoglobinopathies2
Iron Overload2
Thalassemia2
Anemia1
Anemia, Hemolytic1

Trials

Showing 26 to 22 of 22. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.